share_log

雲頂新耀-B：截至二零二三年十二月三十一日止月份之股份發行人的證券變動月報表

EVEREST MED-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 5 04:46
Summary by Moomoo AI
雲頂新耀-B（云顶新耀-B）於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持在500,000,000股，每股面值0.0001美元，總額50,000美元。已發行股份從上月的323,571,794股增加至323,704,720股，增加132,926股。該增加主要源於股份期權計劃的行使，其中包括首次公開發售前管理層及員工購股權計劃，以及首次公開發售後購股權計劃。本月內因行使期權所得資金總額為186,900.86港元。此外，報告還確認了公司在本月發行的每項證券均已獲得董事會的正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
雲頂新耀-B（云顶新耀-B）於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持在500,000,000股，每股面值0.0001美元，總額50,000美元。已發行股份從上月的323,571,794股增加至323,704,720股，增加132,926股。該增加主要源於股份期權計劃的行使，其中包括首次公開發售前管理層及員工購股權計劃，以及首次公開發售後購股權計劃。本月內因行使期權所得資金總額為186,900.86港元。此外，報告還確認了公司在本月發行的每項證券均已獲得董事會的正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Genting Xinyao-B (Genting Xinyao-B) filed with Hong Kong Trading and Settlement Limited on 5 January 2024 the Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulated/registered share capital remained at 500,000,000 shares with a face value of $0.0001 per share for a total of $50,000. The issued shares increased to 323,704,720 shares from 323,571,794 shares in the previous month, an increase of 132,926 shares. The increase stems primarily from the exercise of share option schemes, which include the pre-IPO management and employee stock option schemes, and the IPO post-IPO share option scheme. The total amount of proceeds from the exercise of the option during the month was HK$186,900.86. In addition, the report confirmed that each of the securities issued by the company this month had received formal approval from the Board of Directors and complied with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Genting Xinyao-B (Genting Xinyao-B) filed with Hong Kong Trading and Settlement Limited on 5 January 2024 the Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulated/registered share capital remained at 500,000,000 shares with a face value of $0.0001 per share for a total of $50,000. The issued shares increased to 323,704,720 shares from 323,571,794 shares in the previous month, an increase of 132,926 shares. The increase stems primarily from the exercise of share option schemes, which include the pre-IPO management and employee stock option schemes, and the IPO post-IPO share option scheme. The total amount of proceeds from the exercise of the option during the month was HK$186,900.86. In addition, the report confirmed that each of the securities issued by the company this month had received formal approval from the Board of Directors and complied with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more